Search

everythinglearnresearchcommunity

for

Search:↓

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Diet changes can protect against harmful environmental effects on fetal development.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Finasteride effectively treats baldness but may cause sexual side effects.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Hair grays due to oxidative stress and fewer functioning melanocytes.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.